Chemotherapy-Induced Peripheral Neuropathy – Epidemiology and Pathogenesis
Dariusz Iżycki(Poznan University of Medical Sciences), Ewa Nowak‐Markwitz(Poznan University of Medical Sciences), Adam Niezgoda(Poznan University of Medical Sciences), Maciej Kaźmierczak(Silesian University of Technology)
Cited by 11
Related Papers
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
|Blood Advances|2020|109
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
|Journal of Clinical Oncology|2022|93
Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR
|International Journal of Oncology|2017|80